Aethlon Medical (NASDAQ:AEMD – Get Free Report) will be announcing its earnings results after the market closes on Thursday, June 27th. Analysts expect the company to announce earnings of ($1.18) per share for the quarter.
Aethlon Medical Stock Down 0.3 %
AEMD stock traded down $0.00 during midday trading on Monday, reaching $0.60. 843,817 shares of the company’s stock traded hands, compared to its average volume of 2,247,523. The company has a market cap of $1.57 million, a price-to-earnings ratio of -0.12 and a beta of 1.60. The firm’s fifty day moving average price is $0.87 and its 200-day moving average price is $1.48. Aethlon Medical has a 52 week low of $0.37 and a 52 week high of $5.00.
Wall Street Analyst Weigh In
Several research firms recently weighed in on AEMD. StockNews.com began coverage on shares of Aethlon Medical in a research report on Sunday. They set a “sell” rating for the company. HC Wainwright reduced their price target on shares of Aethlon Medical from $10.00 to $7.00 and set a “buy” rating for the company in a research report on Monday.
Aethlon Medical Company Profile
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
Featured Articles
- Five stocks we like better than Aethlon Medical
- Basic Materials Stocks Investing
- Reddit: Poised for Growth with Data Licensing and OpenAI Deal
- What is a Death Cross in Stocks?
- Top 5 Stocks to Watch for AI-Driven Gains That Aren’t NVIDIA
- EV Stocks and How to Profit from Them
- Why These 3 Stocks Are Getting Upgraded by Analysts
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.